ERBB2 and breast carcinoma: Although the parental DCIS cells used in this study are known to only minimally express Her2 (Chung et al, 2016), we speculate that CAFs up-regulate Her2 expression in DCIS cells and/or increase the Her2-positive tumor cell subpopulation in tumors during tumor progression, facilitating their interaction with breast cancer cells.